Mangoceuticals, Inc. (NASDAQ: MGRX)

Mangoceuticals, Inc. is a telehealth and wellness company that connects consumers with licensed healthcare professionals through its website and provides access to a range of men’s health products.

The company generates revenue primarily from the sale of its compounded pharmaceutical products, which include treatments for erectile dysfunction, hair loss, hormone balance and weight management, as well as the FDA approved testosterone therapy product marketed under the Prime brand. Customers can also purchase these products on a subscription basis to receive regular refills, providing the company with recurring revenue.

Mangoceuticals operates in a competitive market that includes telehealth providers such as Hims & Hers and Roman as well as large pharmaceutical companies like Pfizer, Eli Lilly and Merck that sell branded erectile dysfunction, hair loss and hormone therapies. Its competitive advantages stem from the sublingual delivery format of its products, the integration of telehealth consultations with pharmacy fulfillment, and its focus on branding and direct to consumer marketing.

The company serves adult men who seek treatment for conditions such as erectile dysfunction, hair loss, hormone imbalance and weight management through its telehealth platform. It also serves patients who obtain prescriptions for the FDA approved testosterone therapy product via the same telehealth service.